Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)

Clinical trial NCT06607549 · RECRUITING

Trial details

NCT number: NCT06607549
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Lymphoma

Start date: 2025-03-18
Primary completion: 2029-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.